[Dangerous deficits in management of hypertensive diabetic patients. A kidney check is far from standard procedure].
D000419:Albuminuria / Q000175:diagnosis* / Q000188:drug therapy; D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001713:Biphenyl Compounds / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis*; D003928:Diabetic Nephropathies / Q000175:diagnosis* / Q000188:drug therapy; D003937:Diagnosis, Differential; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000209:etiology*; D000077405:Irbesartan; D044140:Receptor, Angiotensin, Type 1; D013777:Tetrazoles / Q000627:therapeutic use
D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents; D001713:Biphenyl Compounds; D044140:Receptor, Angiotensin, Type 1; D013777:Tetrazoles; D000077405:Irbesartan